July 27, 2016 - ASM Asks VA for Clarification on Proposed Advance Practice Registered Nurse Duty Changes

ASM comments focus on Advance Practice Nurses ability to perform laboratory testing

ASM Urges Congressional Action on Emergency Zika Funding

The ASM sent a letter to Majority Leader McConnell and Minority Leader Reid, Speaker Ryan and Minority Leader Pelosi urging action on Zika funding legislation.

February 12, 2016 - ASM Letter to Congress Regarding Zika Virus

The ASM sent a letter to Congress supporting the President's supplemental budget request of $1.8 billion to prepare and respond to the Zika virus outbreak.

May 18, 2016 - ASM Supports $1.9 Billion Emergency Funding to Combat Zika

The ASM sent a letter to Congress supporting the full $1.9 emergency funding request to combat Zika.

2016 Statements and Testimony

Statements and Testimony from 2016

May 11, 2016 – ASM Comments on Department of Labor Employee Exemptions Definitions Impact on Research

The ASM sent a letter to Howard A. Shelanski, Ph.D., Administrator, Office of Information and Regulatory Affairs, Office of Management and Budget regarding the impact of the Department of Labor’s “Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales and Computer Employees” on research.

November 4, 2015 - ASM Comments on Identifying Sources of Agricultural Innovation

That ASM sent comments to the Office of Science and Technology Policy (OSTP) regarding an a Request for Information (RFI) on Identifying Sources of Agricultural Innovation.

April 8, 2016 - ASM Letter on Zika and Emerging Infectious Disease Funding

The ASM sent a letter to Congress regarding emergency funding for the Zika outbreak.  The ASM supports providing new funding to fight public health emergencies.

ASM Advisory on the Report of the Fast-Track Action Committee on Mapping the Microbiome

The ASM sent out an advisory to members regarding the Report of the Fast-Track Action Committee on Mapping the Microbiome.

Department of Defense - FY 2017

The ASM submitted funding recommendations to Congress for the U.S. Department of Agriculture for fiscal year 2017.

December 2, 2015 - ASM Letter Regarding the Report of the Fast-Track Action Committee on Mapping the Microbiome

The ASM sent a letter to Dr. John Holdren, Director of the Office of Science and Technology Policy and Shaun Donovan, Director of the Office of Management and Budget regarding the Report of the Fast-Track Action Committee on Mapping the Microbiome.  The report was published by the Life Sciences Subcommittee of the National Science and Technology Council.

Department of Energy - FY 2017

The ASM submitted funding recommendations to Congress for the Department of Energy for fiscal year 2017.

November 19, 2015 - ASM Comments on Proposed Changes to Human Subject Protection Regulations (Common Rule)

ASM applauds proposed changes in the Human Subject Protection Regulations that would exclude the use of spent, de-identified human specimens for routine validation of diagnostic tests, as well as other quality assurance activities and asks that that this exclusion from oversight be expanded to include all research on de-identified specimens that do not involve analysis of human genetic material.

PSAB Funding Statements from 1997

The content of this page is restricted to ASM Members only.

Please login at the top-right or to become a member, join ASM.

November 10, 2015 - ASM Recommendations for the FDA FY 2016 Budget

The ASM sent funding recommendations to the Committees on Appropriations for the FDA FY 2016 budget.  

March 14, 2016 - ASM Comments on Select Agents and Toxins Regulations

The ASM sent comments to the Centers for Disease Control and Prevention (CDC) and the Animal and Plant Health Inspection Service (APHIS) regarding the biennial review of the List of Select Agents and Toxins and enhanced biosafety requirements. 

October 6, 2015 - ASM Letter in Response to the Antimicrobial Resistance Rapid Point of Care Diagnostic Test Challenge

The Department of Health and Human Services (HHS) is  holding a prize competition in which up to $20 million will be made available, subject to the availability of funds, for the delivery of one or more successful rapid point-of-care diagnostics that may be used by health care providers to identify bacterial infections.  The National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) are sponsoring the prize competition and invited public comments regarding the technical criteria and performance characteristics of the diagnostics for which the prize will be offered.  The development and use of rapid, point-of-care, and innovative diagnostic tests for identification and characterization of resistant bacteria was a goal identified in the National Strategy for Combating Antibiotic-Resistant Bacteria released in September 2014  and addressed in the National Action Plan for Combating Antibiotic-Resistant Bacteria released in March 2015.The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are contributing technical and regulatory expertise to develop the award evaluation process.

ASM Funding Recommendations to Congress for Fiscal Year 2017

The ASM has submitted appropriation recommendations to Congress for federal agencies that support biomedical and public health research.

 

September 22, 2015 – ASM Comments on Cost Increase for the Drug Pyrimethamine

The ASM sent a letter to Turing Pharmaceuticals regarding the company’s recent 5,000 percent cost increase for the decades old generic drug pyrimethamine (Daraprim).

U.S. Department of Agriculture - FY 2017

The ASM submitted funding recommendations to Congress for the U.S. Department of Agriculture for fiscal year 2017.

September 18, 2015 - ASM Sends Letter to Members of Congress on Antibiotic Tax Credit Bill

The ASM sent a letter to Representatives Boustany and Thompson regarding their proposed Antibiotic and Rapid Diagnostic Research and Development Tax Credit Act of 2015.  The legislation is designed to accelerate discovery of novel tools against drug resistant microbial pathogens.

National Science Foundation - FY 2017

The ASM submitted funding recommendations to Congress for the National Science Foundation for fiscal year 2017.

September 8, 2015 – ASM Poses Questions to CMS on Implementation of IQCP

The ASM submitted questions to the Administrator of the Centers for Medicare and Medicaid Services (CMS) on the implementation of Individualized Quality Control Plans (IQCPs) in the clinical microbiology laboratory.  The answers sought will allow ASM to assist clinical microbiologists prepare for implementation of their own IQCPs by the deadline of January 2016.  

Food and Drug Administration - FY 2017

The ASM submitted funding recommendations to Congress for the Food and Drug Administration for fiscal year 2017.

August 24, 2015 - ASM Comments on the List of Select Agents and Toxins

The ASM submitted comments to the Centers for Disease Control and Prevention on the possession, use, and transfer of select agents and toxins.  The comments addressed adding certain Influenza virus strains to the List of Select Agents and Toxins.

Centers for Disease Control and Prevention - FY 2017

The ASM submitted funding recommendations to Congress regarding funding for the Centers for Disease Control and Prevention for fiscal year 2017.

August 17, 2015 - ASM Comments on NIH RFI on the Framework for the NIH-wide Strategic Plan

The ASM submitted comments to the National Institutes of Health (NIH) RFI on the Framework for the NIH-wide Strategic Plan.  The comments will help NIH develop a 5-year strategic plan to outline a vision for biomedical research that will pursue fundamental knowledge about the nature and behavior of living systems and apply that knowledge to extend healthy life and reduce illness and disability.

National Institutes of Health - FY 2017

The ASM submitted funding recommendations to Congress about the National Institutes of Health for FY 2017.

August 17, 2015 - ASM Comments on Department of State and Commerce Control Regulations for Certain Pathogens

The ASM submitted comments to the US Department of Commerce and the US State Department regarding the Category XIV materials (Toxicological Agents, Including Chemical Agents, Biological Agents, and Associated Equipment) included on the United States Munitions List and the Commerce Control List.

February 19, 2016 - ASM Letter Supports Increased AFRI Funding

The ASM sent a letter to Congress supporting a funding level of $700 million in the FY 2017 budget for the U.S. Department of Agriculture’s Agriculture and Food Research Initiative (AFRI).

TPL_asm2013_SEARCH

137